Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients
Published
Regeneron Pharmaceuticals said Friday it has paused a clinical study of its antibody drug to treat some of the sickest COVID-19 patients...
Full ArticlePublished
Regeneron Pharmaceuticals said Friday it has paused a clinical study of its antibody drug to treat some of the sickest COVID-19 patients...
Full ArticleWatch VideoMonoclonal antibodies or “antibody cocktails” are getting a lot of attention as the next promising treatment in the..